These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 2805571)

  • 21. Treatment of frostbite with the calmodulin antagonists thioridazine and trifluoperazine.
    Beitner R; Chen-Zion M; Sofer-Bassukevitz Y; Morgenstern H; Ben-Porat H
    Gen Pharmacol; 1989; 20(5):641-6. PubMed ID: 2606333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of tritoqualine on anaphylactic and anaphylactoid shock in rats, evaluated by renal enzyme excretion studies.
    Raab W
    Med Exp Int J Exp Med; 1969; 19(5):301-11. PubMed ID: 4393124
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of intraventricular administration of calcium and calmodulin antagonist on the blood pressure in the rat.
    Sutoo D; Matsukura T; Akiyama K
    Neurosci Lett; 1987 Dec; 82(3):297-302. PubMed ID: 2962018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Alkaline phosphatase activity of rat serum after anaphylactoid shock].
    Raab W
    Experientia; 1966 May; 22(5):317-8. PubMed ID: 5957220
    [No Abstract]   [Full Text] [Related]  

  • 25. [The decrease of the kininogen content of plasma in toxic, anaphylactic and anaphylactoid shock].
    Greeff K; Scharnagel K; Lühr R; Strobach H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1966; 253(2):235-45. PubMed ID: 4222742
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of various nucleic acid and protein synthesis inhibitors on anaphylactoid inflammation in rats.
    Koltai M; Minker E
    Eur J Pharmacol; 1969 May; 6(2):175-82. PubMed ID: 5796804
    [No Abstract]   [Full Text] [Related]  

  • 27. Molecular weight studies on the active constituents of compound 48-80.
    Read GW; Lenney JF
    J Med Chem; 1972 Mar; 15(3):320-3. PubMed ID: 5059219
    [No Abstract]   [Full Text] [Related]  

  • 28. The mechanism of the anaphylactoid phenomenon.
    GROSS P; BROWN JH
    Am J Med Sci; 1951 Jan; 221(1):46-50. PubMed ID: 14789782
    [No Abstract]   [Full Text] [Related]  

  • 29. Putative therapeutic applications of calmodulin antagonists.
    Mannhold R; Timmerman H
    Pharm Weekbl Sci; 1992 Aug; 14(4):161-6. PubMed ID: 1437493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of anaphylactoid shock in the rat by the calmodulin antagonist thioridazine.
    Grollmuss O; Sanchez-Delgado E; Bader H
    Clin Physiol Biochem; 1989; 7(5):229-37. PubMed ID: 2805571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The anti-anaphylactic effect of the gall of Rhus javanica is mediated through inhibition of histamine release and inflammatory cytokine secretion.
    Kim SH; Park HH; Lee S; Jun CD; Choi BJ; Kim SY; Kim SH; Kim DK; Park JS; Chae BS; Shin TY
    Int Immunopharmacol; 2005 Dec; 5(13-14):1820-9. PubMed ID: 16275618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gamijeonssibaekchulsan regulates mast cell-mediated anaphylactic reaction.
    Moon PD; Shin HY; Na HJ; Jeong HJ; Kim SJ; Um JY; Park RK; Kim HM; Hong SH
    Acta Biochim Pol; 2007; 54(2):349-55. PubMed ID: 17546203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mosla dianthera inhibits mast cell-mediated allergic reactions through the inhibition of histamine release and inflammatory cytokine production.
    Lee DH; Kim SH; Eun JS; Shin TY
    Toxicol Appl Pharmacol; 2006 Nov; 216(3):479-84. PubMed ID: 16890260
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.